Latest European Patent Office Stories
- Patent Protection for NB32 for Treating Insulin Resistance - SAN DIEGO, Sept. 2, 2014 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that the U.S.
TAIPEI, July 29, 2014 /PRNewswire/ -- Apex Medical Corporation (Apex, TWSE: 4106), a leading player in the Respiratory Therapy and Pressure Area Care sectors, announces that it is appealing
JENA, Germany, July 23, 2014 /PRNewswire/ -- Occlutech, a leading European developer of minimally invasive implants for therapy in structural heart disease, today announced
Copan’s attack was blown away by the District Court Düsseldorf. Guilford, ME (PRWEB) July 17, 2014 At an oral hearing on June 24, 2014 (case no.
HAMM, Germany, May 9, 2014 /PRNewswire/ -- In December 2011, Align Technology filed a patent infringement lawsuit against Ortho Caps GmbH (maker of orthocaps(R) aligners)
--PDL's Revolutionary Antibody Technology Provided Basis for Eight Successful Drugs Currently on the Market-- INCLINE VILLAGE, Nev., May 6, 2014 /PRNewswire/ -- PDL BioPharma, Inc.
FALLS CHURCH, Va., April 21, 2014 /PRNewswire-USNewswire/ -- Acentia, a premier provider of technology and management solutions, today announced it was awarded a 1-year, $2.5-million contract
BRUSSELS, Belgium, March 6, 2014 /PRNewswire/ -- -- Almost a quarter of all European patent filings originate from the US -- US patent filings in Europe grew by 2.8% to highest
BRUSSELS, March 6, 2014 /PRNewswire/ -- - European Patent Office announces record numbers of patent filings and patent grants - UK applicants
- A transitional zone between two communities containing the characteristic species of each.